15 C
Santiago
lunes, diciembre 18, 2017
Inicio European Union

European Union

CORPORACION
  1. The European Commission has sent a Statement of Objections to Facebook alleging the company provided incorrect or misleading information during the Commission's 2014 investigation under the EU Merger Regulation of Facebook's planned acquisition of WhatsApp. December 20th, 2016.
  2. On 29 August 2014, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation, and following a referral pursuant to Article 4(5) of the Merger Regulation, by which Facebook, Inc. ("Facebook", USA) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of WhatsApp Inc. ("WhatsApp", USA) by way of purchase of shares (the "Transaction"). Jointly, Facebook and WhatsApp are designated hereinafter as the "Parties". October 03rd, 2014.

No hay publicaciones para mostrar

DESTACADOS

Medicamentos de alto costo y patentes farmacéuticas ¿la salud primero?

Medicamentos de alto costo y patentes farmacéuticas ¿la salud primero? Para más información.. http://opinion.cooperativa.cl/opinion/salud/medicamentos-de-alto-costo-y-patentes-farmaceuticas-la-salud-primero/2017-11-25/071003.html  

HOT NEWS